Key statistics
As of last trade, Disc Medicine Inc (IRON:NMQ) traded at 62.80, 103.76% above the 52 week low of 30.82 set on Apr 09, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 55.67 |
|---|---|
| High | 65.06 |
| Low | 55.51 |
| Bid | 62.63 |
| Offer | 62.97 |
| Previous close | 55.95 |
| Average volume | 1.18m |
|---|---|
| Shares outstanding | 37.75m |
| Free float | 34.48m |
| P/E (TTM) | -- |
| Market cap | 2.11bn USD |
| EPS (TTM) | -5.35 USD |
Data delayed at least 15 minutes, as of Feb 17 2026 17:14 GMT.
More ▼
Announcements
- Disc Medicine Receives Complete Response Letter from FDA for Bitopertin for the Treatment of EPP
- Disc Medicine Appoints Lisa Amaya Price, MBA as Chief Human Resources Officer
- Disc Medicine Highlights Recent Achievements and Key Business Objectives and Milestones for 2026
- Disc Medicine to Present at the 44th Annual J.P. Morgan Healthcare Conference
- Disc Medicine Presents Positive Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting
- Disc Medicine Reports Third Quarter 2025 Financial Results and Provides Business Update
- Disc Medicine Announces Presentation of Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting
- Disc Medicine to Participate in Upcoming Investor Conferences
- Disc Medicine Announces Pricing of $250 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants
- Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
More ▼
